Updated hourlyHourly refreshFri, Sep 4, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Replimune Group, Inc. (NASDAQ:REPL) securities. If you suffered a loss on your Replimune Group, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Replimune Group, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
Sep 3 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired UWM Holdings Corporation (NYSE:UWMC) securities. If you suffered a loss on your UWM Holdings Corporation investment and would like to explore a potential recovery under the federal securities laws, Learn about UWM Holdings Corporation Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
Sep 3 · 17:05·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE:HIMS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Hims securities between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: ..
Sep 3 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Insulet Corporation ("Insulet Corporation" or "the Company") (NASDAQ:PODD). Investors who purchased Insulet Corporation securities prior to May 21, 2026, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/insulet-corporation-podd-derivative_lawsuit. Insulet Corporation Investigation Details The investigation concerns whether Insulet Corporation and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Insulet Corporation Investors? If you are aware of any facts relating ..
Sep 3 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against York Space Systems, Inc. (NYSE:YSS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired York securities: (1) pursuant to the registration statement and prospectus issued in connection with the Company's January 29, 2026 initial public offering ("IPO"); or (ii) between January 29, 2026, and ..
Sep 3 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of D-Wave Quantum Inc. ("D-Wave" or "the Company") (NASDAQ:QBTS). Investors who purchased D-Wave securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/d-wave-quantum-inc-qbts-class_action_lawsuit. D-Wave Investigation Details On August 6, 2026, D-Wave reported its financial results for the second quarter of 2026. Among other items, D-Wave issues revenue of only $3.08 million, compared to $3.1 million for the same period in the prior year, and missing analyst expectations in the range ..
Sep 3 · 17:05·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SELLAS Life Sciences Group, Inc. ("SELLAS" or "the Company") (NASDAQ:SLS). Investors who purchased SELLAS securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/sellas-life-sciences-group-inc-sls-class_action_lawsuit. SELLAS Investigation Details On August 28, 2026, a news site reported that the Company's phase 3 clinical trial for Galinpepimut-S (GPS) had reached its 80th patient death, a pre-specified event that was to trigger the release of results for the clinical trial. However, as of ..
Sep 3 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Innventure, Inc. (NASDAQ:INV) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Innventure securities between November 17, 2025 and August 13, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/innventure-inc-inv-class_action_lawsuit. Innventure Case Details The ..
Sep 3 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against XTI Aerospace, Inc. (NASDAQ:XTIA) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired XTI Aerospace securities between April 15, 2026 and August 17, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/xti-aerospace-inc-xtia-class_action_lawsuit. XTI ..
Sep 3 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Snowflake Inc. ("Snowflake Inc." or "the Company") (NYSE:SNOW). Investors who purchased Snowflake Inc. securities prior to June 27, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SNOW. Snowflake Inc. Investigation Details The investigation concerns whether Snowflake Inc. and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Snowflake Inc. Investors? If you are aware of any facts relating ..
Sep 3 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nektar Therapeutics ("Nektar" or "the Company") (NASDAQ:NKTR). Investors who purchased Nektar securities prior to February 26, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NKTR. Nektar Investigation Details The investigation concerns whether Nektar and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Nektar Investors? If you are aware of any facts relating to this investigation or purchased ..
Sep 3 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 3, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Blue Owl Capital Inc. ("Blue Owl" or "the Company") (NYSE:OWL). Investors who purchased Blue Owl securities prior to February 6, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OWL. Blue Owl Investigation Details The investigation concerns whether Blue Owl and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Blue Owl Investors? If you are aware of any ..
Sep 3 · 17:05·PR-Inside